Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy

• Published in: PLoS pathogens Vol. 18; no. 8; p. e1010756
• Main Authors: Zhao, Xiujuan, Lin, Xiaojing, Li, Ping, Chen, Zinuo, Zhang, Chengcheng, Manicassamy, Balaji, Rong, Lijun, Cui, Qinghua, Du, Ruikun
• Format: Journal Article
• Language: English
• Published: San Francisco Public Library of Science 04.08.2022; Public Library of Science (PLoS)
• Subjects: Animal models; Biology and life sciences; Compensation; Competition; Drug resistance; Exploitation; Gene expression; Gene mutations; Genetic aspects; Genetic engineering; Genomes; Infections; Influenza; Influenza A; Influenza viruses; Medicine and health sciences; Mutation; Optimization; Protein expression; Proteins; Research and Analysis Methods; RNA polymerase; Segments; Vaccines; Virulence; Viruses; China
• ISSN: 1553-7374; 1553-7366; 1553-7374
• DOI: 10.1371/journal.ppat.1010756

Reporter viruses provide powerful tools for both basic and applied virology studies, however, the creation and exploitation of reporter influenza A viruses (IAVs) have been hindered by the limited tolerance of the segmented genome to exogenous modifications. Interestingly, our previous study has demonstrated the underlying mechanism that foreign insertions reduce the replication/transcription capacity of the modified segment, impairing the delicate balance among the multiple segments during IAV infection. In the present study, we developed a “balance compensation” strategy by incorporating additional compensatory mutations during initial construction of recombinant IAVs to expand the tolerance of IAV genome. As a proof of concept, promoter-enhancing mutations were introduced within the modified segment to rectify the segments imbalance of a reporter influenza PR8-NS-Gluc virus, while directed optimization of the recombinant IAV was successfully achieved. Further, we generated recombinant IAVs expressing a much larger firefly luciferase (Fluc) by coupling with a much stronger compensatory enhancement, and established robust Fluc-based live-imaging mouse models of IAV infection. Our strategy feasibly expands the tolerance for foreign gene insertions in the segmented IAV genome, which opens up better opportunities to develop more versatile reporter IAVs as well as live attenuated influenza virus-based vaccines for other important human pathogens.